Clinical Features and Outcomes of Pasteurella multocida Infection

Antonio Giordano1, Toros Dincman, Benjamin E Clyburn

  • 1From the Department of Internal Medicine (AG, TD, BEC, DCR); and Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Department of Medicine, Charleston, South Carolina (LLS).

Medicine
|September 11, 2015
PubMed

Insights

Pasteurella multocida infections without an animal bite are linked to higher risks of bacteremia, hospitalization, and mortality. These non-bite cases often indicate severe underlying conditions and require intensive care.

Area of Science:

  • Infectious Diseases
  • Bacteriology
  • Public Health

Background:

  • Pasteurella multocida is a zoonotic bacterium commonly associated with animal bites.
  • Clinical presentation and outcomes of P. multocida infections can vary significantly.
  • Understanding non-bite-related infections is crucial for comprehensive patient management.

Purpose of the Study:

  • To characterize clinical features and outcomes of P. multocida infections.
  • To compare P. multocida infections with and without a history of animal bites.
  • To identify risk factors and prognostic indicators in P. multocida infections.

Main Methods:

  • Retrospective cohort study of patients with positive P. multocida cultures (2000-2014).
  • Data abstraction included clinical details, comorbidities (Charlson Comorbidity Index - CCI), and outcomes.
  • Statistical analysis to compare patient groups based on the presence or absence of an animal bite.

Main Results:

  • 44 patients identified; 25 had animal bites.
  • Non-bite P. multocida infections were associated with higher rates of bacteremia (37% vs 4%) and hospitalization (84% vs 44%).
  • Severe comorbidities (CCI ≥1) and intensive care unit (ICU) needs were more frequent in non-bite cases; all 4 deaths occurred in non-bitten patients.

Conclusions:

  • P. multocida infections unrelated to animal bites present with more severe clinical manifestations.
  • Non-bite P. multocida infections are often linked to significant comorbidities and poorer outcomes.
  • Early recognition and management are vital for P. multocida infections, especially in non-bite scenarios.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
46
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
801
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
40
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
446
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.2K